Invesco NASDAQ Biotechnology ETF
IBBQ
22 hedge funds and large institutions have $11.6M invested in Invesco NASDAQ Biotechnology ETF in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
47% more funds holding
Funds holding: 15 → 22 (+7)
25% more capital invested
Capital invested by funds: $9.26M → $11.6M (+$2.3M)
2.52% less ownership
Funds ownership: 33.68% → 31.15% (-2.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$1.15M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$566K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$317K |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$129K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$77.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$287K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$33.8K |
| 3 |
SFC
Strategic Financial Concepts
San Antonio,
Texas
|
-$3.67K |
| 4 |
Morgan Stanley
New York
|
-$34 |
IBBQ Hedge Fund Activity: Q3 2024 in Review
22 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q3 2024, worth a combined $11.6M — up 25% from $9.26M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new IBBQ positions and 2 closed out — a net gain of 7 holders — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Mirae Asset Global Investments, adding an estimated $1.15M. The largest seller was Royal Bank of Canada, cutting an estimated $287K.
- 22 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q3 2024, up from 15 in Q2 2024.
- Funds reported $11.6M of Invesco NASDAQ Biotechnology ETF stock for Q3 2024, up 25% quarter-over-quarter.
- 9 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q3 2024 and 2 closed out, a net change of +7 holders.
- The largest Invesco NASDAQ Biotechnology ETF buyer in Q3 2024 was Mirae Asset Global Investments, an estimated $1.15M added.
- The largest Invesco NASDAQ Biotechnology ETF seller in Q3 2024 was Royal Bank of Canada, an estimated $287K sold.
Based on aggregated 13F filings for Q3 2024.